Van Lanschot Kempen Logo
Search
Van Lanschot Kempen Logo
Search

Transactions 2025

September 2025
BioArtctic
Joint Bookrunner
SEK 720 million
Sale of existing shares
Right Arrow in Circle
August 2025
tag
Joint Bookrunner
€186 million
Accelerated Bookbuild Offering
Right Arrow in Circle
July 2025
transaction logo image
Co-Manager
USD 748 million
US Public Offering
Right Arrow in Circle
July 2025
maat-pharma-logo
Financial Adviser
€37.5 million
Venture Debt Financing
Right Arrow in Circle
July 2025
pharvaris
Joint Bookrunner
USD 201 million
US Public Offering
Right Arrow in Circle
June 2025
transaction logo image
Joint Global Coordinator and Joint Bookrunner
SEK 1 billion
Accelerated Bookbuild Offering
Right Arrow in Circle
June 2025
Amvest
Financial Adviser
€ 300 million
Green Bond
Right Arrow in Circle
June 2025
merus-logo
Lead Manager
USD 300 million
US Public Offering
Right Arrow in Circle
May 2025
Rinkelberg Capital Logo
Sole Financial Adviser
c. €120 million
Sell-side M&A
Right Arrow in Circle
April 2025
galapagos
Sole Financial Adviser
Sale of immunology and oncology programmes to Onco3R Therapeutics
Right Arrow in Circle
March 2025
DBV
Co-Placement Agent
(up to) USD 307 million
PIPE (Equity & Warrants)
Right Arrow in Circle
March 2025
maat-pharma-logo
Placement Agent
€13 million
PIPE
Right Arrow in Circle
January 2025
vastned
Sole Financial Adviser
€1.3 billion
Reverse Merger with Vastned Belgium
Right Arrow in Circle
March 2025
transaction logo image
Sole Financial Adviser
€185 million
Royalty financing agreement
Right Arrow in Circle
January 2025
transaction logo image
Sole Financial Adviser
€508 million
Buy-side M&A
Right Arrow in Circle
January 2025
Xior logo
Joint Global Coordinator and Joint Bookrunner
€80 million
Accelerated Bookbuild Offering
Right Arrow in Circle
March, 2025
Logo MaaT Pharma in blue
€13 million
Right Arrow in Circle